Related Experiment Video
Updated: May 29, 2026
08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Reproductive factors and Parkinson's disease: a multicenter case-control study
Alessandra Nicoletti1, Giuseppe Nicoletti, Gennarina Arabia
1Dipartimento Ingrassia Sezione di Neuroscienze, Università di Catania, Catania, Italy.
Movement Disorders : Official Journal of the Movement Disorder Society
|September 30, 2011
Summary
Oral contraceptives may increase the risk of developing Parkinson's disease (PD). This study found a significant positive association between oral contraceptive use and PD in women.
Area of Science:
- Neurology
- Epidemiology
- Endocrinology
Background:
- Investigating the link between estrogen exposure and Parkinson's disease (PD) risk.
- Examining both endogenous and exogenous estrogen sources.
Purpose of the Study:
- To determine if estrogen use, including oral contraceptives and hormone replacement therapy, influences PD development.
- To assess the association between various reproductive factors and PD risk in women.
Main Methods:
- A multicenter case-control study (FRAGAMP) involving 200 women with PD and 299 controls.
- Standardized questionnaires collected demographic, epidemiological, and clinical data.
- Multivariate logistic regression analyzed adjusted odds ratios (ORs) and 95% confidence intervals (CIs).
Main Results:
- No significant association was found between PD and age at menarche, menopause, fertile life duration, pregnancy duration, hormone replacement therapy, or surgical menopause.
- A significant positive association was observed between oral contraceptive use and PD (adjusted OR = 3.27, 95% CI = 1.24-8.59, P = .01).
Conclusions:
- Findings suggest oral contraceptives might elevate the risk of developing Parkinson's disease.
- Further research is warranted to confirm this association and elucidate potential mechanisms.
Related Concept Videos
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.